Pharmaceutical Uridine-5-Triphosphoric Acid Trisodium UTP-Na3 ISO Certified UTP-Na3

• Customization: Available
• CAS No.: 19817-92-6
• Formula: C9h12n2na3o15p3
• Model NO.: QS-UTP-Na3
• EINECS: 243-347-5
• Packaging Material: Negotiable
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: UTP-Na3
• Resource: UTP-Na3
• The content of active substances: >99%
• Product Name: UTP-Na3
• Name: UTP-Na3 Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: Pharmaceutica
• Specific: COA
• Test Method: HPLC
• Mf: C9h12n2na3o15p3
• Mv: 550.085
• Melting Point: 140c
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-UTP-Na3
• Origin: Xi`an
• Production Capacity: 10kg/Month

Product Description

Pharmaceutical Uridine-5-Triphosphoric Acid Trisodium UTP-Na3 ISO Certified UTP-Na3

Product Description

Product Details

Name	UTP-Na3 Powder
Product Name	UTP-Na3
Appearance	White Powder
Assay	>99%
Application	Pharmaceutica
Melting Point	140C
MF	C9H12N2Na3O15P3
MV	550.085

 

Uridine triphosphate trisodium salt is a nucleotide that regulates pancreatic endocrine and exocrine functions, proliferation, channels, transponders, and intracellular signaling during normal and disease states.
 

Application&Function

cell signaling transduction
UTP-Na3 is an important cellular signaling molecule, particularly in the extracellular purinergic signaling system. UTP can activate specific P2Y receptor subtypes (such as P2Y2, P2Y4, P2Y6), which play a key role in regulating cell proliferation, differentiation, inflammatory response, and other physiological processes.
Research on Nucleic Acid and Nucleotide Metabolism
UTP-Na3 is a precursor for RNA synthesis in vivo and participates in the transcription process catalyzed by RNA polymerase. In addition, it also plays an important role in sugar metabolism, especially in the synthesis pathway of glycosides.
Drug Development
UTP-Na3 is being studied for the development of novel drugs, particularly for diseases related to respiratory tract and inflammation. The mucous secretion regulatory effect of UTP makes it a potential drug for treating diseases such as cystic fibrosis and chronic obstructive pulmonary disease (COPD).

Specification